Catalyst Wire Dossier Catalyst Wire Dossier

Arikayce

amikacin liposome inhalation suspension · Insmed Incorporated
Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for Arikayce, covering 2016-10-14 to 2025-12-05. Get the full timeline:

Most recent: FDA Approved: ARIKAYCE — Supplemental Application (Insmed Incorporated)

See pricing